(Sharecast News) - Analysts at Berenberg said Hiscox's "underpriced momentum" offered clear upside for investors, arguing the shares failed to reflect the insurer's accelerating top‑line growth and improving operating leverage.
Berenberg noted the stock trades on around 10x two‑year blended forward earnings - roughly a 10% discount to the sector -...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE